NEIL GARRY ARTHUR 4
4 · Avalo Therapeutics, Inc. · Filed Dec 12, 2022
Insider Transaction Report
Form 4
NEIL GARRY ARTHUR
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2022-12-09$4.42/sh+2,083$9,207→ 9,220 total
Footnotes (1)
- [F1]These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.